La ciencia que sustenta la radioterapia

+ -Text Size

TEMAS

Referencias

American Society for Therapeutic Radiology and Oncology. Answers to Your Radiation Therapy Questions. Accessed at www.rtanswers.org on October 23, 2014.

Brown AP, Chen J, Hitchcock YJ, et al. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab. 2008;93(2):504-515.

Constine LS, Milano MT, Friedman D, et al. Late Effects of Cancer treatment on Normal Tissues. In: Halperin EC, Perez CA, Brady LW, (Eds.) Perez and Brady’s Principles and Practice of Radiation Oncology, 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008: 320-355.

Douglas JG, Goodkin R, Laramore GE. Gamma knife stereotactic radiosurgery for salivary gland neoplasms with base of skull invasion following neutron radiotherapy. Head Neck. 2008;30(4):492-496.

Fisher DR. Medical Isotope Production and Use (National Isotope Development Center). 2009. Accessed at www.isotopes.gov/outreach/reports/Medical_Isotope_Production_Use.pdf on October 23, 2014.

Gosselin-Acomb TK. Principles of Radiation Therapy. In: Henke Yarbro C, Hansen Frogge M, Goodman M, eds. Cancer Nursing Principles and Practice. 6th ed. Boston: Jones and Bartlett Publishers, Inc. 2005:229-249.

Halperin EC. Particle therapy and treatment of cancer. Lancet Oncol. 2006;7:676-685.

Halperin EC, Perez CA, Brady LW (eds). Principles and Practice of Radiation Oncology, Fifth Ed. Philadelphia, Pa: Lippincott Williams & Wilkins 2008.

Hede K. Research groups promoting proton therapy “lite.” JNCI. 2006;98:1682-1684.

International Atomic Energy Agency, Radiation Protection of Patients. Radiation Protection in Radionuclide therapy. Accessed at http://rpop.iaea.org/RPOP/RPoP/Content/Documents/TrainingNuclearMedicine/Lectures/RPNM_Part08_therapy_WEB.ppt on October 23, 2014.

Jongen Y. Radiotherapy systems using proton and carbon beams. Bull Mem Acad R Med Belg. 2008;163(10-12):471-478; discussion 479-480.

Khan FM. The Physics of Radiation Therapy. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins 2010.

Kry SF, Salehpour M, Followill DS, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62(4):1195-1203.

Morgan MA, Haken RKT, Lawrence TS. Radiation Oncology. In: DeVita VT Jr, Lawrence TS, Rosenberg SA (Eds.) DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology, 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011: 289-311.

National Cancer Institute. Radiation Therapy and You: Support for People With Cancer. Accessed at www.cancer.gov/cancertopics/radiation-therapy-and-you on October 23, 2014.

National Cancer Institute. Radiation Therapy for Cancer FactSheet. Accessed at www.cancer.gov/cancertopics/factsheet/Therapy/radiation on October 23, 2014.

Paes FM, Serafini AN. Systemic Metabolic Radiopharmaceutical Therapy in the Treatment of Metastatic Bone Pain. Semin Nucl Med. 2010;40:89-104.

Reed SI. Cell Cycle. In: DeVita VT Jr, Lawrence TS, Rosenberg SA (Eds.) DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology, 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011: 68-81.

Sheets NC, Goldin GH, Meyer AM, et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA. 2012;307(15):1611-1620.


Fecha de última actualización: 12/12/2014
Fecha de último cambio o revisión: 12/12/2014